Raloxifene Hydrochloride is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM) that belongs to the benzothiophene class of compounds.
This report contains market size and forecasts of Raloxifene Hydrochloride Tablets in global, including the following market information:
Global Raloxifene Hydrochloride Tablets Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Raloxifene Hydrochloride Tablets Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Raloxifene Hydrochloride Tablets companies in 2021 (%)
The global Raloxifene Hydrochloride Tablets market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Original Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Raloxifene Hydrochloride Tablets include Eli Lilly, Apotex Corporation, Teva Pharmaceutical, Jiangsu Hengrui Medicine, Aurobindo Pharma, Glenmark Pharmaceuticals, Sciegen Pharmaceuticals and Prasco Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Raloxifene Hydrochloride Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Raloxifene Hydrochloride Tablets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Raloxifene Hydrochloride Tablets Market Segment Percentages, by Type, 2021 (%)
Original Drugs
Generic Drugs
Global Raloxifene Hydrochloride Tablets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Raloxifene Hydrochloride Tablets Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Raloxifene Hydrochloride Tablets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Raloxifene Hydrochloride Tablets Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Raloxifene Hydrochloride Tablets revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Raloxifene Hydrochloride Tablets revenues share in global market, 2021 (%)
Key companies Raloxifene Hydrochloride Tablets sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Raloxifene Hydrochloride Tablets sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
Apotex Corporation
Teva Pharmaceutical
Jiangsu Hengrui Medicine
Aurobindo Pharma
Glenmark Pharmaceuticals
Sciegen Pharmaceuticals
Prasco Laboratories